GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Geron Corporation (GERN) [hlAlert]

Rating:
Buy GERN
down 27.35 %

Geron Corporation (GERN) upgraded to Buy by Merriman Curhan Ford

Posted on: Thursday,  Dec 11, 2008  11:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Geron Corporation (NASDAQ: GERN) on 12/11/2008, when the stock price was $4.24. Since
then, Geron Corporation has lost 27.36% as of 01/25/2016's recent price of $3.08.
If you would have followed this Merriman Curhan Ford's recommendation on GERN, you would have lost 27.35% of your investment in 2601 days.

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/11/2008 11:25 AM Buy
None
4.24
as of 12/24/2008
1 Week down  -8.51 %
1 Month up  3.03 %
3 Months   
1 YTD up  5.78 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/11/2008 8:25 AM Hold
None
4.36

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy